Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.47 is 87% below its 5-year average of 18.92, near the low end of its 5-year range (2.47–137.62).
As of the fiscal period ended Tuesday, June 30, 2026. 46.59% below its 12-month average of 4.62.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.47.
CURRENT RATIO
2.47
CURRENT RATIO AVG TTM
4.62
CURRENT RATIO AVG 3Y
11.01
CURRENT RATIO AVG 5Y
18.92
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-46.59%
CURRENT VS 3Y AVG
-77.60%
CURRENT VS 5Y AVG
-86.96%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 509 covered companies
CURRENT VS SECTOR MEDIAN
-26.40%
vs the sector median at left
Acumen Pharmaceuticals, Inc.
Market Cap
$154.57M
Current Ratio
2.47
TTM Avg
4.62
3Y Avg
11.01
5Y Avg
18.92
Market Cap
$153.84M
Current Ratio
15.62
TTM Avg
10.23
3Y Avg
11.93
5Y Avg
11.24
Market Cap
$153.31M
Current Ratio
5.55
TTM Avg
4.34
3Y Avg
4.83
5Y Avg
5.46
Market Cap
$147.02M
Current Ratio
19.47
TTM Avg
11.39
3Y Avg
11.91
5Y Avg
15.23
Market Cap
$160.13M
Current Ratio
9.71
TTM Avg
4.67
3Y Avg
6.04
5Y Avg
19.74
Market Cap
$143.81M
Current Ratio
0.82
TTM Avg
5.49
3Y Avg
4.19
5Y Avg
4.20
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | $154.57M | 2.47 | 4.62 | 11.01 | 18.92 |
| Anavex Life Sciences Corp. (AVXL)vs › | $153.84M | 15.62 | 10.23 | 11.93 | 11.24 |
| Cardiol Therapeutics Inc. (CRDL)vs › | $153.31M | 5.55 | 4.34 | 4.83 | 5.46 |
| LifeMD, Inc. (LFMDP)vs › | $154.72M | 0.90 | 1.03 | 0.91 | 1.08 |
| Codexis, Inc. (CDXS)vs › | $150.59M | 3.06 | 4.00 | 3.48 | 4.36 |
| Inogen, Inc. (INGN)vs › | $160.82M | 2.74 | 2.77 | 3.26 | 3.97 |
| Immuneering Corporation (IMRX)vs › | $147.02M | 19.47 | 11.39 | 11.91 | 15.23 |
| ALX Oncology Holdings Inc. (ALXO)vs › | $160.13M | 9.71 | 4.67 | 6.04 | 19.74 |
| Korsana Biosciences, Inc. (KRSA)vs › | $143.81M | 0.82 | 5.49 | 4.19 | 4.20 |
| Fortress Biotech, Inc. (FBIOP)vs › | $142.49M | 3.96 | 1.88 | 1.73 | 2.58 |
Current Ratio
2.47
Quick Ratio
2.47
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.47 |
| 2026-03-31 | 4.55 |
| 2025-12-31 | 4.07 |
| 2025-09-30 | 6.02 |
| 2025-06-30 | 5.97 |
| 2025-03-31 | 8.02 |
| 2024-12-31 | 6.46 |
| 2024-09-30 | 10.43 |
| 2024-06-30 | 17.37 |
| 2024-03-31 | 30.20 |
| 2023-12-31 | 19.01 |
| 2023-09-30 | 35.85 |
| 2023-06-30 | 17.53 |
| 2023-03-31 | 16.41 |
| 2022-12-31 | 23.08 |
| 2022-09-30 | 30.63 |
| 2022-06-30 | 37.21 |
| 2022-03-31 | 48.81 |
| 2021-12-31 | 38.60 |
| 2021-09-30 | 137.62 |
| 2021-06-30 | 15.62 |
| 2021-03-31 | 1.35 |
| 2020-12-31 | 6.98 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
